参考区间再探讨:使用小样本量和生物变异数据的基于人群的参考区间新模型。

IF 7.1 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY
Abdurrahman Coşkun, Sverre Sandberg, Ibrahim Unsal, Deniz I Topcu, Aasne K Aarsand
{"title":"参考区间再探讨:使用小样本量和生物变异数据的基于人群的参考区间新模型。","authors":"Abdurrahman Coşkun, Sverre Sandberg, Ibrahim Unsal, Deniz I Topcu, Aasne K Aarsand","doi":"10.1093/clinchem/hvae109","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Conventional population-based reference intervals (popRIs) are established on the ranking of single measurement results from at least 120 reference individuals. In this study, we aimed to explore a new model for popRIs, utilizing biological variation (BV) data to define the reference interval (RI) limits and compared BV-based popRI from different sample sizes with previously published conventional popRIs from the same population.</p><p><strong>Methods: </strong>The model is based on defining the population set point (PSP) from single-measurement results of a group of reference individuals and using the total variation around the PSP, derived from the combination of BV and analytical variation, to define the RI limits. Using data from 143 reference individuals for 48 clinical chemistry and hematology measurands, BV-based popRIs were calculated for different sample sizes (n = 16, n = 30, and n = 120) and considered acceptable if they covered 90% of the population. In addition, simulation studies were performed to estimate the minimum number of required reference individuals.</p><p><strong>Results: </strong>The median ratio of the BV-based to conventional RI ranges was 0.98. The BV-based popRIs calculated from the different samples were similar, and most met the coverage criterion. For 25 measurands ≤16 reference individuals and for 23 measurands >16 reference individuals were required to estimate the PSP.</p><p><strong>Conclusions: </strong>The BV-based popRI model delivered robust RIs for most of the included measurands. This new model requires a smaller group of reference individuals than the conventional popRI model and can be implemented if reliable BV data are available.</p>","PeriodicalId":10690,"journal":{"name":"Clinical chemistry","volume":" ","pages":"1279-1290"},"PeriodicalIF":7.1000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reference Intervals Revisited: A Novel Model for Population-Based Reference Intervals, Using a Small Sample Size and Biological Variation Data.\",\"authors\":\"Abdurrahman Coşkun, Sverre Sandberg, Ibrahim Unsal, Deniz I Topcu, Aasne K Aarsand\",\"doi\":\"10.1093/clinchem/hvae109\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Conventional population-based reference intervals (popRIs) are established on the ranking of single measurement results from at least 120 reference individuals. In this study, we aimed to explore a new model for popRIs, utilizing biological variation (BV) data to define the reference interval (RI) limits and compared BV-based popRI from different sample sizes with previously published conventional popRIs from the same population.</p><p><strong>Methods: </strong>The model is based on defining the population set point (PSP) from single-measurement results of a group of reference individuals and using the total variation around the PSP, derived from the combination of BV and analytical variation, to define the RI limits. Using data from 143 reference individuals for 48 clinical chemistry and hematology measurands, BV-based popRIs were calculated for different sample sizes (n = 16, n = 30, and n = 120) and considered acceptable if they covered 90% of the population. In addition, simulation studies were performed to estimate the minimum number of required reference individuals.</p><p><strong>Results: </strong>The median ratio of the BV-based to conventional RI ranges was 0.98. The BV-based popRIs calculated from the different samples were similar, and most met the coverage criterion. For 25 measurands ≤16 reference individuals and for 23 measurands >16 reference individuals were required to estimate the PSP.</p><p><strong>Conclusions: </strong>The BV-based popRI model delivered robust RIs for most of the included measurands. This new model requires a smaller group of reference individuals than the conventional popRI model and can be implemented if reliable BV data are available.</p>\",\"PeriodicalId\":10690,\"journal\":{\"name\":\"Clinical chemistry\",\"volume\":\" \",\"pages\":\"1279-1290\"},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2024-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/clinchem/hvae109\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/clinchem/hvae109","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:传统的基于人群的参考区间(popRIs)是根据至少 120 个参考个体的单次测量结果排序确定的。在本研究中,我们旨在探索一种新的流行参考区间模型,利用生物变异(BV)数据来定义参考区间(RI)限值,并将不同样本量的基于 BV 的流行参考区间与之前发表的来自同一人群的传统流行参考区间进行比较:该模型的基础是根据一组参照个体的单次测量结果来定义群体设定点(PSP),并利用 BV 和分析变异组合得出的 PSP 周围的总变异来定义 RI 限制。使用来自 143 个参考个体的 48 种临床化学和血液学测量指标的数据,计算了不同样本量(n = 16、n = 30 和 n = 120)的基于 BV 的流行 RI,如果这些数据覆盖了 90% 的人群,则认为这些数据是可接受的。此外,还进行了模拟研究,以估算所需的最低参照个体数量:结果:基于 BV 的 RI 范围与传统 RI 范围的中位比为 0.98。根据不同样本计算出的基于 BV 的人群 RI 相似,且大多数都符合覆盖标准。有 25 种测量值的参考个体数少于 16 个,有 23 种测量值的参考个体数大于 16 个,才能估算出 PSP:结论:基于 BV 的 popRI 模型为大多数测量指标提供了可靠的 RI。与传统的 popRI 模型相比,这种新模型所需的参照个体较少,如果有可靠的 BV 数据,就可以实施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Reference Intervals Revisited: A Novel Model for Population-Based Reference Intervals, Using a Small Sample Size and Biological Variation Data.

Background: Conventional population-based reference intervals (popRIs) are established on the ranking of single measurement results from at least 120 reference individuals. In this study, we aimed to explore a new model for popRIs, utilizing biological variation (BV) data to define the reference interval (RI) limits and compared BV-based popRI from different sample sizes with previously published conventional popRIs from the same population.

Methods: The model is based on defining the population set point (PSP) from single-measurement results of a group of reference individuals and using the total variation around the PSP, derived from the combination of BV and analytical variation, to define the RI limits. Using data from 143 reference individuals for 48 clinical chemistry and hematology measurands, BV-based popRIs were calculated for different sample sizes (n = 16, n = 30, and n = 120) and considered acceptable if they covered 90% of the population. In addition, simulation studies were performed to estimate the minimum number of required reference individuals.

Results: The median ratio of the BV-based to conventional RI ranges was 0.98. The BV-based popRIs calculated from the different samples were similar, and most met the coverage criterion. For 25 measurands ≤16 reference individuals and for 23 measurands >16 reference individuals were required to estimate the PSP.

Conclusions: The BV-based popRI model delivered robust RIs for most of the included measurands. This new model requires a smaller group of reference individuals than the conventional popRI model and can be implemented if reliable BV data are available.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical chemistry
Clinical chemistry 医学-医学实验技术
CiteScore
11.30
自引率
4.30%
发文量
212
审稿时长
1.7 months
期刊介绍: Clinical Chemistry is a peer-reviewed scientific journal that is the premier publication for the science and practice of clinical laboratory medicine. It was established in 1955 and is associated with the Association for Diagnostics & Laboratory Medicine (ADLM). The journal focuses on laboratory diagnosis and management of patients, and has expanded to include other clinical laboratory disciplines such as genomics, hematology, microbiology, and toxicology. It also publishes articles relevant to clinical specialties including cardiology, endocrinology, gastroenterology, genetics, immunology, infectious diseases, maternal-fetal medicine, neurology, nutrition, oncology, and pediatrics. In addition to original research, editorials, and reviews, Clinical Chemistry features recurring sections such as clinical case studies, perspectives, podcasts, and Q&A articles. It has the highest impact factor among journals of clinical chemistry, laboratory medicine, pathology, analytical chemistry, transfusion medicine, and clinical microbiology. The journal is indexed in databases such as MEDLINE and Web of Science.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信